A Case of Osteitis Fibrosa Cystica of the Mandible
A Rare Presentation during Pregnancy due to CDC73 Mutation
DOI:
https://doi.org/10.15605/jafes.039.02.17Keywords:
osteitis fibrosa cystica, primary hyperparathyroidism, pathological fracture, skeletal manifestationAbstract
Primary hyperparathyroidism (PHPT) typically results from parathyroid adenoma, multiglandular hyperplasia, or parathyroid carcinoma. Patients usually present with skeletal manifestations such as low-trauma fractures. Osteitis fibrosa cystica (OFC) is a classic yet rare skeletal manifestation of advanced PHPT currently reported in less than 2% of patients. We present a case of a 29-year-old Indian female who presented with a femur fracture and mandibular OFC 20 days after delivery. The painless mandibular swelling gradually progressed from the third month of pregnancy. The biochemical and radiological investigations were indicative of PHPT-associated OFC. After the excision of the three-and-a-half parathyroid gland, histology revealed benign cystic adenomas and hyperplasia. Based on the associated clinical manifestations, OFC was suspected. Clinical exome sequencing revealed CDC73(+) c.687_688dupAG heterogenous pathogenic autosomal dominant mutation. Undiagnosed PHPT in mothers during pregnancy led to neonatal hypocalcaemic convulsions. With adequate supplementation, the infant recovered completely from transient congenital hypoparathyroidism. OFC is an important diagnosis to consider in a young patient with swelling of the neck and jaw. Simultaneous high levels of PTH and serum calcium should raise a high index of suspicion for OFC. Parathyroidectomy helps manage the biochemical abnormalities and causes regression of the jaw mass that causes facial disfigurement and attenuates the declining BMD. Children born to mothers with PHPT should be evaluated for neonatal hypoparathyroidism and supplemented appropriately to reduce the risk of hypocalcaemic manifestations that can be life-threatening. If the CDC73 mutation is detected, the offspring should be monitored for signs of PHPT due to the high probability of inheritance and parathyroid malignancy.
Downloads
References
1. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122-9. https://pubmed.ncbi.nlm.nih.gov/23418315 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590475 https://doi.org/10.1210/jc.2012-4022
2. McCarthy A, Howarth S, Khoo S, et al. Management of primary hyperparathyroidism in pregnancy: A case series. Endocrinol Diabetes Metab Case Rep. 2019;2019:19-0039. https://pubmed.ncbi.nlm.nih.gov/31096181 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528402 https://doi.org/10.1530/EDM-19-0039
3. Bringhurst FD, Demay MB, Kronenberg HM. Chapter 28 - Hormones and disorders of mineral metabolism. Williams textbook of endocrinology (13th ed). 2016. https://doi.org/10.1016/B978-0-323-29738-7.00028-9
4. Vanitcharoenkul E, Singsampun N, Unnanuntana A, et al. Osteitis fibrosa cystica and pathological fractures-the classic but neglected skeletal manifestation of primary hyperparathyroidism: A case report. BMC Musculoskelet Disord. 2021;22(1):443. https://pubmed.ncbi.nlm.nih.gov/33990191 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122575 https://doi.org/10.1186/s12891-021-04326-1
5. Guerrouani A, Rzin A, El Khatib K. Hyperparathyroidism-jaw tumour syndrome detected by aggressive generalized Osteitis fibrosa cystica. Clin Cases Miner Bone Metab. 2013;10(1):65-7. https://pubmed.ncbi.nlm.nih.gov/23858315 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710014 https://doi.org/10.11138/ccmbm/2013.10.1.065
6. Kalapala L, Keerthi Sai S, Babburi S, et al. An endocrine jaw lesion: Dentist perspective in diagnosis. Case Rep Dent. 2016;2016:2582038. https://pubmed.ncbi.nlm.nih.gov/27974979 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126398 https://doi.org/10.1155/2016/2582038.
7. Satpathy AS, Dasgupta A, Dutta C, Mohan NVK, Satpathy S. Osteitis fibrosa cystica of mandible in hyperparathyroidism-jaw tumor syndrome: A rare presentation and review of literature. Natl J Maxillofac Surg. 2017;8(2):162-6. https://pubmed.ncbi.nlm.nih.gov/29386822 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773993 https://doi.org/10.4103/njms.NJMS_48_17
8. Naji Rad S, Deluxe L. Osteitis Fibrosa Cystica. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK559097/
9. Parfitt J, Harris M, Wright JM, Kalamchi S. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized Osteitis fibrosa cystica: A case report and genetic pathophysiology review. J Oral Maxillofac Surg. 2015;73(1):194.e1-9. https://pubmed.ncbi.nlm.nih.gov/25511968 https://doi.org/10.1016/j.joms.2014.09.008
10. Chapter 3 – Anesthesia. Clinical Review of Oral and Maxillofacial Surgery (Second Edition), Mosby; 2014. https://doi.org/10.1016/B978-0-323-17126-7.00003-0
11. Pillai SS, Foster CA, Ashraf AP. Approach to neonatal hypocalcemia. Newborn 2022;1(1):190–6. https://doi.org/10.5005/jp-journals-11002-0017
12. Casteràs A, Darder L, Zafon C, et al. Brown tumor of the jaw after pregnancy and lactation in a MEN1 patient. Endocrinol Diabetes Metab Case Rep. 2016;2016:16-0111. https://pubmed.ncbi.nlm.nih.gov/27933172 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118968 https://doi.org/10.1530/EDM-16-0111
13. Malekar-Raikar S, Sinnott BP. Primary hyperparathyroidism in pregnancy-a rare cause of life-threatening hypercalcemia: Case report and literature review. Case Rep Endocrinol. 2011;2011:520516. https://pubmed.ncbi.nlm.nih.gov/22937284 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420708
https://doi.org/10.1155/2011/520516
14. Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, O’Fallon WM, Riggs BI. Primary hyperparathyroidism and the risk of fracture: A population-based study. J Bone Miner Res. 1999;14(10):1700-7. https://pubmed.ncbi.nlm.nih.gov/10491217 https://doi.org/10.1359/jbmr.1999.14.10.1700
15. Sizar O, Khare S, Goyal A, Givler A. Vitamin D deficiency. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK532266/
16. Singh DN, Gupta SK, Kumari N, et al. Primary hyperparathyroidism presenting as hypercalcemic crisis: Twenty-year experience. Indian J Endocrinol Metab. 2015;19(1):100-5. https://pubmed.ncbi.nlm.nih.gov/25593835 Phttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287752 https://doi.org/10.4103/2230-8210.131763
17. Mestman JH. Parathyroid disorders of pregnancy. Semin Perinatol. 1998;22(6):485-96. https://pubmed.ncbi.nlm.nih.gov/9880118 https://doi.org/10.1016/s0146-0005(98)80028-1
18. Vuralli D. Clinical approach to hypocalcemia in newborn period and infancy: Who should be treated? Int J Pediatr. 2019;2019:4318075. https://pubmed.ncbi.nlm.nih.gov/31320908 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607701 https://doi.org/10.1155/2019/4318075
19. Norman J, Politz D, Politz L. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: A call for earlier intervention. Clin Endocrinol (Oxf). 2009;71(1):104-9. https://pubmed.ncbi.nlm.nih.gov/19138316 https://doi.org/0.1111/j.1365-2265.2008.03495.x
20. Kokrdova Z. Pregnancy and primary hyperparathyroidism. J Obstet Gynaecol. 2010;30(1):57-9. https://pubmed.ncbi.nlm.nih.gov/20121508 https://doi.org/10.3109/01443610903315611
21. Truong MT, Lalakea ML, Robbins P, et al. Primary hyperparathyroidism in pregnancy: A case series and review. Laryngoscope. 2008;118(11):1966-9. https://pubmed.ncbi.nlm.nih.gov/18758377 https://doi.org/10.1097/MLG.0b013e318180276f
22. Sun W, Kuang XL, Liu YP, Tian LF, Yan XX, Zu W. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Sci Rep. 2017;7(1):15638. https://pubmed.ncbi.nlm.nih.gov/29142233 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688130 https://doi.org/10.1038/s41598-017-15715-9
23. Skefos CM, Waguespak SG, Perrier ND, Hu MI. CDC73-Related Disorders. In: Adam MP, Everman DB, Mirzaa GM, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2022. https://www.ncbi.nlm.nih.gov/books/NBK3789/
24. NM_024529.5(CDC73):c.687_688dup(p.Val230fs). https://www.ncbi.nlm.nih.gov/clinvar/variation/241496/#new-germline-citation
25. Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24. https://pubmed.ncbi.nlm.nih.gov/25741868 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544753 https://doi.org/10.1038/gim.2015.30
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pratibha Pawal, Anand Nikalje, Yash Chauhan, Premlata Varthakavi, Nikhil Bhagwat
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.